Cell-mediated immunity was evaluated in patients with diabetes mellitus by delayed hypersensitivity skin tests and in vitro lymphocyte transformations. Only 44% of diabetic patients had skin test reactivity to Candida antigen, compared with 88% of normal controls (P < 0.001). Insulin-dependent diabetic (IDD) patients had abnormally low lymphocyte transformation responses to phytohemagglutinin, concanavalin A, and streptokinase-streptodornase (P < 0.05 
Patients with diabetes mellitus have an increased incidence of infections caused by bacteria, virus, and fungi (19, 20) . Immune deficiencies are often invoked to explain their increased incidence of infections and morbid complications.
Although humoral immunity appears to be normal in most diabetic patients (8) , several types of functional abnormalities have been demonstrated in polymorphonuclear leukocytes, particularly when the patients are in ketoacidosis (2, 4, 11, 15) .
Studies of cell-mediated immunity of the delayed type (CMI) have shown conflicting data in patients with diabetes mellitus (3, 5, 9, 16 ). CMI appears to be important in host defenses against certain infections, especially those caused by fungi and mycobacteria (6, 7, 12, 17) .
The purpose of this study was to investigate CMI in diabetic patients by utilizing delayed hypersensitivity skin tests, in vitro lymphocyte transformations, and an assay of lymphocyte suppressor activity.
MATERIALS AND not statistically significant. A significant reduction in SI occurred with the specific antigen SK-SD in the NIDD groups (P < 0.05). In contrast, lymphocytes from the 38 IDD patients had very low mean indexes of transformation to PHA (SI = 37) and ConA (SI = 30), as well as to SK-SD (SI = 5). All these differences were statistically significant when compared with control values (P < 0.05). Transformations of unstimulated cultures without antigens were similar in all three groups, with mean counts per minute between 403 and 446.
A correlation was also noted in the IDD group between the SIs to PHA and the level of hyperglycemia. Mean SI with PHA was 27 in the IDD group with FSG levels of >200 mg/dl and 51 in the IDD patients with FSG levels of <200 mg/ dl. Both of these IDD groups had significantly lower mean SIs than did nondiabetic controls (SI = 75 to PHA; P < 0.05). The mean SI with PHA of the six patients in ketoacidosis (22 ± 16) was no different than of those with FSG levels of >200 mg/dl (27 ± 21).
Suppressor activity in lymphocyte cultures. An assay of suppressor activity was performed on lymphocyte cultures from 15 IDD patients and 25 controls. No suppressor activity was seen in any control patients in this assay (suppressor indexes, 50 to 100%), except for one whose suppressor index was 108% (Fig. 1) lymphocyte transformations were found in these diabetic patients.
Longitudinal studies. Lymphocytes of seven IDD patients were studied at least three times with PHA mitogen over a 12-month period (Fig. 2) . Four of these IDD patients had improved diabetic control as seen by reductions in their levels of hyperglycemia (FSG levels were reduced from >200 to <150 mg/dl). Two of these patients (no. 1 and 2) were started on insulin at the onset of this study. A third patient (no. 3) was hospitalized in the middle of the year for control of her diabetes and subsequently had increases in lymphocyte responses to PHA (SIs increased from 50 to 100). Patient no. 4 had been on insulin for 1 year, but her FSG levels were >200 mg/dl. Further regulation of her insulin dosage reduced her FSG levels to <150 mg/dl, and her SIs to PHA increased from 34 to 54.
Three other patients (no. 5, 6, and 7) had consistently elevated FSG levels (>200 mg/dl) or repeated episodes of keotacidosis (no. 5 variety of pathogens (19, 20) . The spectrum of these organisms suggests that multiple defects occur in several areas of their immune system.
Defects have been found in acute inflammatory
responses of diabetic patients in ketoacidosis as measured by the skin window technique (15) . In vitro function studies of polymorphonuclear leukocytes have shown frequent abnormalities in chemotaxis, phagocytosis, and intracellular killing of bacteria, especially in the poorly controlled IDD (2, 4, 11).
Whereas granulocytic leukocytes are important in defending against bacterial infections, CMI is thought to play a dominant role in protecting against fungal infections (6, 7, 12, 17) .
Conflicting data have been reported on the status of CMI in diabetics. In 1970 terial and viral antigens, diabetics had significant reductions in response to a fungal skin test antigen. These patients with negative Candida skin tests did not have widespread disease and antigen overload such as is seen in chronic mucocutaneous candidiasis (7) . Conflicting data reported in earlier studies can probably be explained best by the state of diabetic control in these study populations. These abnormal lymphocyte transformations may revert to normal responses with reduction of the hyperglycemia. We have no data as to whether the incidence of infections correlates with these lymphocyte studies. As immunological tools become more sophisticated, the basic derangement of lymphocyte function may be explained. Abnormalities may exist in membrane receptors for mitogens in these cells, as has been noted in diabetics for insulin (1), or they may reflect intracellular defects in metabolism. We have not investigated the role of the macrophage, and it is possible that abnormal macrophage function could explain in vivo and in vitro defects of CMI. These studies also may have therapeutic implications for diabetic patients with disseminated or deepseated fungal disease. Along with better diabetic control and antibiotics, immunological agents such as transfer factor or immunoadjuvants may have a role in bolstering or augmenting CMI.
